Carboplatin‐induced renal salt‐wasting syndrome in pediatric patients with intracranial germ cell tumors and concomitant diabetes insipidus
- 7 February 2022
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 69 (5) , e29592
Abstract
We report a case series of 14 children with intracranial germ cell tumor and concomitant central diabetes insipidus, who developed hyponatremia secondary to renal salt‐wasting syndrome (RSWS) following the administration of carboplatin. Clinicians prescribing platinum‐based chemotherapy for this group of patients should be alert to the risk of RSWS. Regular monitoring should be performed as hyponatremia can be asymptomatic until it is severe.Keywords
All Related Versions
This publication has 12 references indexed in Scilit:
- Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International ConsortiumEuropean Journal of Cancer, 2018
- Renal toxicity and chemotherapy in children with cancerBritish Journal of Clinical Pharmacology, 2017
- Central Diabetes Insipidus and Cisplatin-Induced Renal Salt Wasting Syndrome: A Challenging CombinationPediatric Blood & Cancer, 2016
- Differential diagnosis of hyponatremia induced by cisplatin-containing chemotherapy: syndrome of inappropriate secretion of antidiuretic hormone (SIADH) or renal salt wasting syndrome (RSWS)Acta Oto-Laryngologica Case Reports, 2016
- Cisplatin-Induced Renal Salt Wasting SyndromeSouthern Medical Journal, 2010
- A Review of Drug-Induced HyponatremiaAmerican Journal of Kidney Diseases, 2008
- Central Diabetes Insipidus in Children and Young AdultsNew England Journal of Medicine, 2000
- Dose-related nephrotoxicity of carboplatin in childrenBritish Journal of Cancer, 1999
- Recurrent renal salt wasting in a child treated with carboplatin and etoposideCancer, 1994
- Intracranial germ-cell tumors: natural history and pathogenesisJournal of Neurosurgery, 1985